2017 International Congress Archives - Page 39 of 155

Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)
Large CAG expansions in Huntington disease children: the RAREST-JHD initiative

F. Squitieri, M. Marano, S. Migliore, S. Maffi, F. consoli, E. Bidollari, J. Rosati, A. Ciammola, E. Gatto, E. Cortes, A. Ilari, J. Vonsattel, U. Sabatini (Rome, Italy)
Laryngeal Tardive Dyskinesia in a Patient treated with Haldol

R. Joseph, F. Amjad (Columbus, OH, USA)
Late-Onset Wilson’s disease, Dementia, Ekbom syndrome and whitte matter hyperintensities

F. Germiniani, P. Marques, F. Zorzetto, L. de Oliveira, H. Teive (Curitiba, Brazil)
Lateralization of fine motor actions in Tourette syndrome persisting through adulthood

D. Martino, C. Delorme, E. Pelosin, A. Hartmann, Y. Worbe, L. Avanzino (Calgary, AB, Canada)
Leg Stereotypy Disorder: Clinical Characteristics and Prevalence

J. Jankovic, M. Lotia, M. York, A. Strutt (Houston, TX, USA)
Levodopa effect and motor function in late stage Parkinson’s disease

K. Rosqvist, P. Odin, M. Horne, P. Hagell, S. Iwarsson, M. Nilsson (Lund, Sweden)
Levodopa induced dyskinesia in a case of progressive supranuclear palsy.

T. Yamamoto, H. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, K. Takahashi, N. Tamura, N. Araki (Saitama, Japan)
Levodopa responsiveness in Parkinson’s disease is significantly impaired in those with diabetes and increased vascular risk.

N. Malek, M. Lawton, K. Grosset, N. Bajaj, R. Barker, Y. Ben-Shlomo, D. Burn, T. Foltynie, J. Hardy, H. Morris, N. Williams, N. Wood, D. Grosset (Ipswich, United Kingdom)
Levodopa/carbidopa Intestinal Gel Can Improve Both Motor and Non-Motor Experiences of Daily Living in Parkinson’s Disease: An Open-Label Study

N. Kovacs, A. Juhász, Z. Aschermann, P. Ács, J. Janszky, M. Kovács, A. Makkos, M. Harmat, D. Tényi, K. Katádi, S. Komoly, A. Takáts, A. Tóth, H. Nagy, P. Klivényi, G. Dibó, L. Dézsi, D. Zádori, Á. Annus, L. Vécsei, L. Varannai (Pécs, Hungary)
Lifelong daily workload and postural abnormalities in patients with Parkinson’s disease

T. Maeda (Morioka, Japan)
Lifetime exposure to estrogen and risk for progressive supranuclear palsy

H.K. Park, I. Litvan, S. Ilango (Goyang-si, Republic of Korea)
Link between striatal dopamine uptake and cortical dysconnectivity in Parkinson’s disease

A. Greuel, M. Tahmasian, F. Schwartz, S. Aschenberg, F. Maier, L. Timmermann, A. Drzezga, M. Tittgemeyer, C. Eggers (Cologne, Germany)
Listen to your heart: ordinal pattern statistics reveal altered cardiac rhythm dynamics in LRRK2-nonmanifesting carriers

C. Carricarte Naranjo, C. Marras, N. Visanji, A. Lang, L. Sanchez-Rodriguez, A. Machado García (La Habana, Cuba)
Living with Ataxia in Ireland 2016–a nationwide survey of 130 Irish patients with inherited Ataxia

P. Bogdanova-Mihaylova, R. Walsh, S. Murphy (Dublin, Ireland)
Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease

P. Morrison, I. Richard (Rochester, NY, USA)
Long-Term Dopamine Transporter Imaging and Clinical Effects of the Mixed-Lineage Kinase Inhibitor CEP-1347 in the PRECEPT Parkinson Trial

I. Shoulson, S.E. Eberly, D. Oakes, A. Lang, M. Schwarzschild, C. Tanner, J. Seibyl, K. Marek (Washington, DC, USA)
Long-term effect of botulinum toxin injection in the external oblique muscle to treat camptocormia in three patients with Parkinson’s disease.

H. Todo (Sanda, Japan)
Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)
Long-term levodopa therapy accelerates the circadian rhythm dysfunction in 6-OHDA rat model

D. Lv, Y. Wang, F. Wang, X. Zhang, X. Gu, Y. Yang (Suzhou, China)
Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort

D. Aleksovski, D. Miljkovic, A. Antonini (Ljubljana, Slovenia)
Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study

K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Washington, DC, USA)
Longitudinal analysis of the relation of dopamine agonist use with impulse control disorders in Parkinson’s disease

j.-c. corvol, F. Artaud, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, f. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, v. Mesnage, P.C. Lee, A. Brice, M. Vidailhet, F. Cormier-Dequaire, A. Elbaz (Paris, France)
Longitudinal AV-1451 PET imaging in Progressive Supranuclear Palsy and Cortico-Basal Syndrome

A. Sierowf, M. Grossman, D. Russell, I. Litvan, E. Roberson, A. Boxer, M. Devous, M. Navitsky, I. Kennedy, M. Lu, S. Doyle, M. Pontecorvo, M. Mintun (Philadelphia, PA, USA)
Longitudinal changes in speech and voice functions after subthalamic stimulation in Parkinson’s disease patients

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)
Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson’s disease

W. Li, N. Lao-Kaim, A.-A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R. Barker, P. Piccini (London, United Kingdom)
Longitudinal Cortical Thickness Changes in GBA-Positive Relative to GBA-negative Parkinson’s Disease Patients with Hemiparkinsonism

I. Stankovic, N. Kresojevic, F. Agosta, V. Markovic, E. Sarasso, P. Valsasina, I. Petrovic, M. Filippi, V. Kostic (Belgrade, Serbia)
Longitudinal Study of Cortico-Striatal Functional Connectivity in Huntington’s Disease Measured with High-Field Functional MRI.

M. Kronenbuerger, M. Kronenbuerger, J. Hua, X. Mia, P. Unschuld, P. van Zijl, C. Ross (Baltimore, MD, USA)
Longitudinal study of freezing of gait in patients with Parkinson’s disease

M. Sawada, K. Wada-Isoe, S. Tagashira, K. Nakashima (Tottori, Japan)
Longitudinal white matter microstructural change in Parkinson’s disease

C. Gallagher, V. Pozorski, J. Oh, F. Theisen, N. Adluru, A. Alexander (Madison, WI, USA)
Loss of PDE10A expression in patients with PDE10A and ADYC5 mutations

F. Niccolini, N. Mencacci, E. Rabiner, V. Salpietro, G. Pagano, B. Balint, H. Houlden, R. Gunn, N. Wood, K. Bhatia, M. Politis (London, United Kingdom)
Low frequency Deep Brain stimulation for Parkinson’s disease – Effect on freezing of gait.

R. Gopalakrishnan, G. Hosurkar (Bangalore, India)
Low Incidence of Extrapyramidal Symptoms in Subjects with Tardive Dyskinesia Receiving Long-Term Valbenazine (NBI-98854) Treatment

S. Lessig, R. Kurlan, S. Factor, J. Burke, C. Wright, R. Jimenez, G. Liang (La Jolla, CA, USA)
Low-frequency repetitive transcranial cerebellar magnetic stimulation as an ‘add-on’ therapy in patients with Essential Tremor

H.-W. Shin, M. Hallett, Y. Sohn (Bethesda, MD, USA)
Lower education level is associated with greater disability from pain in Parkinson’s disease patients

A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)
Lower urinary tract symptoms in patients with Parkinson’s Disease: findings from a Tunisian cohort

A. Nasri, M. Ben Djebara, Y. Sidhom, K. Achour, I. Kacem, A. Gargouri, R. Gouider (Manouba, Tunisia)